PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy

Xia Pu, Michelle A.T. Hildebrandt, Charles Lu, Jie Lin, David J. Stewart, Yuanqing Ye, Jian Gu, Margaret R. Spitz, Xifeng Wu

Research output: Contribution to journal › Article › peer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences